These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3813487)
1. Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion. Lindahl B; Alm P; Fernö M; Grundsell H; Norgren A; Tropé C Anticancer Res; 1986; 6(6):1317-20. PubMed ID: 3813487 [TBL] [Abstract][Full Text] [Related]
2. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion. Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559 [TBL] [Abstract][Full Text] [Related]
3. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [TBL] [Abstract][Full Text] [Related]
4. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma. Lindahl B; Alm P; Borg A; Fernö M; Grundsell H; Johnsson JE; Norgren A; Tropé C Anticancer Res; 1982; 2(4):203-7. PubMed ID: 7149649 [TBL] [Abstract][Full Text] [Related]
6. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018 [TBL] [Abstract][Full Text] [Related]
7. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma. Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832 [TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma. Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417 [TBL] [Abstract][Full Text] [Related]
9. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1]. Backe J; Gassel AM; Müller T; Schön S; Kaesemann H Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973 [TBL] [Abstract][Full Text] [Related]
10. The distribution and prognostic implications of steroid receptors in endometrial carcinomas. Utaaker E; Iversen OE; Skaarland E Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774 [TBL] [Abstract][Full Text] [Related]
11. Identification of high-risk groups in endometrial carcinoma stage I-II. A combination of DNA- and steroid receptor-measurements identifies early deaths from the disease. Lindahl B; Ranstam J; Norgren A; Willén R Anticancer Res; 1995; 15(3):1095-100. PubMed ID: 7645932 [TBL] [Abstract][Full Text] [Related]
12. Sex steroid receptors in endometrial cancer. Chambers JT Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591 [TBL] [Abstract][Full Text] [Related]
14. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691 [TBL] [Abstract][Full Text] [Related]
15. The prognostic importance of steroid receptors in endometrial carcinoma. Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554 [TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptor content and lymph node status in endometrial cancer. Morris PC; Anderson JR; Anderson B; Buller RE Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676 [TBL] [Abstract][Full Text] [Related]
17. Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma. Pijnenborg JM; Romano A; Dam-de Veen GC; Dunselman GA; Fischer DC; Groothuis PG; Kieback DG J Pathol; 2005 Apr; 205(5):597-605. PubMed ID: 15726651 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of steroid receptor concentration and flow cytometrical DNA measurements in stage I-II endometrial carcinoma. Lindahl B; Alm P; Fernö M; Killander D; Långström E; Norgren A; Tropé C Acta Oncol; 1989; 28(4):595-9. PubMed ID: 2789839 [TBL] [Abstract][Full Text] [Related]
20. Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma. De Góis NM; Martins NV; Abrão FS; De Lima GR; Alves AC Rev Paul Med; 1993; 111(3):385-90. PubMed ID: 8108630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]